BBlogFlow

KukiMAT: Ready to respond when every minute counts - World Health Organization (WHO)

·4d ago
Source: World Health Organization (WHO)
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

For the Cook Islands, emergencies do not always happen close to the capital. A cyclone, disease outbreak, or emergency can affect communities in the Pa Enua (outer islands), separated by hundreds of kilometres of ocean. When that happens, having the capacity to quickly deploy trained personnel, equipment, and supplies to provide an initial clinical response is essential. That is why the Cook Islands Medical Assistance Team (KukiMAT), the emergency medical team arm of Te Marae Ora (TMO) – Cook Islands Ministry of Health, has been steadily building its readiness to respond. Made up of doctors, nurses, public health professionals and support personnel, the team is preparing to be able to rapidly deploy wherever help is needed, whether in Rarotonga, the Pa Enua, and one day perhaps beyond the country’s shores. In Rarotonga, we met with Dr Deacon Teapa, Medical Specialist and Director of Hospital Health Services at TMO. He explained how important it was to build the capacity of their team to be able to respond to disasters and emergencies. He acknowledged the support of the World Health Organization (WHO) and other partners including the New Zealand Medical Assistance Team (NZMAT).

This article is an excerpt. To read the full content, visit the original source. World Health Organization (WHO)

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·